Special Issue "Nanoparticles-Based Antimicrobials"
Deadline for manuscript submissions: closed (31 March 2021).
Interests: nanoparticle-based solutions; small molecule drug and gene therapy approaches; MDR-TB; MRSA
2. National School of Professional Training, Volos, Greece
Interests: pharmaceutical nanotechnology; aliphatic polyesters; biopolymers; biodegradable polymers; nanotechnology
Antimicrobials in general, and their extended use in particular, which creates resistance, are presently one of the most serious battles we face worldwide. The ability of microorganisms to resist antimicrobial treatments has a direct impact on the level of public health and consequently carries a heavy economic burden. Nanotechnology provides an innovative tool to address the challenge of antimicrobial resistance. Nanovehicles which are able to shield antibiotics from enzyme deactivation and consequently increase the therapeutic effectiveness of the drug are introduced as a one novel approach.
The main objective of this Special Issue is to bring forward new attempts through the use of nanotechnology, and therefore new materials, in the detection and treatment of antibiotic-resistant pathogenic organisms, either by targeted delivery of the drug or through the use of specific functionalized nanoparticles as weapons of dealing with pathogens or targeting virulent factors.Dr. Sofia A. Papadimitriou
Dr. Alan John Hibbitts
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Drug Delivery
- Targeted Delivery
- Antimicrobial Resistance